New ICD-10 Codes Will Help the T1D Community
On October 1st, the T1D community got a big win: the Centers for Medicare and Medicaid Servies (CMS) introduced a unique ICD-10 code for stage 2 type 1 diabetes (T1D). This addresses a significant gap in clinical care. Prior to this change, clinicians had limited options for coding stage 2 T1D, which resulted in inaccurate […]
Advocating for progress and access
With the support of our grassroots advocates, our work helps advance treatments, influence policy, and improve access to care for those worldwide who need it.
Breaking through to Congress at 2024 Government Day
Our Advocates traveled to D.C. to reintroduce our organization and champion legislation and policy for the T1D community.
We are Breakthrough T1D
As the leading global type 1 diabetes (T1D) research and advocacy organization, we’re here to make every day life with T1D better.
Never Let T1D Dim Your Light
Princess Padmaja Kumari Parmar combats the stigma of T1D as a Global Ambassador for our organization.
Beating the Odds: The Improbable Story of How Perseverance, Belief, and Luck Led to the Approval of the First Life-Changing Immune Therapy for Type 1 Diabetes
The true story of how Tzield (teplizumab), the first disease-modifying therapy approved for use in delaying type 1 diabetes (T1D) onset, made it to market.
Two Highly Engaged Volunteer Leaders Elected to Head Breakthrough T1D’s International Board of Directors
Lisa Fishbone Wallack, an attorney by training and long-time volunteer leader in the greater New England area, will serve as Breakthrough T1D International Board of Directors (IBOD) Chair, succeeding current Chair Grant Beard. Matt Varey, a senior executive at Royal Bank of Canada (RBC) and dedicated volunteer leader in the greater Toronto, Canada, area, will […]
Natalie Stanback: Representing Women in Advocacy
Breakthrough T1D advocate Natalie Stanback knows type 1 diabetes and knows how to get things done on Capitol Hill. She encourages more women to get involved in advocacy.
What Drug Will Be the Next Tzield?
In 2023 alone, there have been several important papers published on disease-modifying therapies (DMT) for type 1 diabetes. This blog explains everything you need to know about several DMTs.
We are Grateful to be a Part of the T1D Community
In 2023, we have made tremendous progress in accelerating cures, improving lives, and advocating for people with T1D and their loved ones. Take a look.
